AbbVie
IPOPublic · North Chicago, United States · Founded 1888
- Headquarters
- North Chicago, Illinois
- Employees
- 10001+
- Founded
- 1888
- Business Model
- B2B
- Type
- Public
About
AbbVie is an American biopharmaceutical company headquartered in North Chicago, Illinois, formed in 2012 as a spin-off from Abbott Laboratories and publicly listed in January 2013. The company researches, develops, and commercializes a broad portfolio of medicines targeting immunology, oncology, neuroscience, eye care, aesthetics, and hepatitis C, with flagship products including Humira, Skyrizi, Rinvoq, Botox, Imbruvica, and Venclexta. AbbVie employs approximately 57,000 people and operates in more than 170 countries, generating $61.2 billion in revenue in 2025.
Summary
AbbVie is a Biotech company based in North Chicago, United States, founded in 1888.
Exit History
2013 (est.)
Acquisitions
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/abbvie"><img src="https://indexed.vc/api/badge/company/abbvie" alt="AbbVie on Indexed.vc" width="260" height="76" /></a>